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Cells for T Cells 
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Human epidermis was separated from dermis by 
means of a suction blister device and dissociated with 
trypsin. The epidermal cell (Ec) suspensions contained 
2-6% Langerhans cells (Lc). Using a new rosette tech-
nique for enrichment of Lc, suspensions were obtained 
that contained 50-92% viable Lc. Ec, enriched Lc, or 
peripheral blood monocytes (Mo) were cocultured with 
or without antigens (Candida albicans, herpes simplex 
virus) and autologous T lymphocytes from sensitized 
donors. Strong proliferative T-cell responses were ob-
tained provided Ec, enriched Lc, or Mo were also pres-
ent. Furthermore, Lc were more effective than similar 
numbers of Mo in inducing T-cell responses to the anti-
gens tested, and Lc did not require the presence of 
significant numbers of keratinocytes to exert this func-
tion. 
Langerhans cells (Lc) represent a minor cell population of 
human squamous epithelium and human epidermis, constitut-
ing 2-6% of the total number of epidermal cells (Ec) . The Lc 
possess Fe and C3 receptors [1) and are weakly phagocytic 
dendritic cells that carry class II molecules (HLA-DR) and the 
T-6 antigen [2-4). Lc seem to play an important role in the 
immune responses of the skin in that they function as antigen-
presenting cells (APC) forT-lymphocyte responses [5,6], pre-
senting antigen in conjunction with their class li molecules. 
For certain antigens they seem to be more effective APC than 
peripheral blood monocytes on a per cell basis [5,6], which 
further emphasizes their probably fundamental role in the local 
immunity of the mucous membranes and the skin. 
Evidence is accumulating that Lc may belong to or be a 
subpopulation of the so-called dendritic cells [7], which may be 
a subset of cells widely distributed in different tissues but 
having functions in common. 
We have compared the antigen-presenting capacity of en-
riched suspensions of Lc and monocytes (Mo). We show that 
similar numbers of enriched Lc are more potent than Mo in 
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Abbreviations: 
APC: antigen-presenting cells 
CA: Candida antigen 
De: dendritic cell(s) 
Ec: epidermal cell(s) 
ETAF: epidermal thymocyte-activating factor 
HSV: herpes simplex virus 
Il-l: interleukin 1 
Lc: Langerhans cell(s) 
MLR: mixed leukocyte reaction 
Mo: monocyte(s) 
NRS: normal rabbit serum 
ORBC: ox red blood cells 
inducing T -cell responses to antigens of herpes simplex virus 
(HSV) and Candida albicans (CA), and that they in all proba-
bility do not require the presence of keratinocytes producing 
epidermal thymocyte-activating factor (ETAF) . 
MATERIALS AND METHODS 
Cell donors 
The cell donors were unrelated inpatients with various skin diseases 
seen at the Department of Dermatology. 
Antigens 
TheCA antigens used were obtained from Allergologisk laboratorium 
A/S, Denmark, batch no. 331/129553. HSV antigen was from Orion 
Diagnostica, Helsinki, Finland, (batch EI. Fl. catalogue no. 428). 
Rabbit Anti-DR Antiserum and Normal Rabbit Serum (NRS) 
The anti-DR antiserum preparation is described elsewhere [8). The 
antiserum and the NRS were heat inactivated (56"C for 30 min) and 
absorbed with pooled human erythrocytes before use. 
1' Lymphocytes 
Purified T lymphocytes were prepared from Isopaque-Ficoll isolated 
peripheral blood mononuclear cells by rosetting with aminoethyl-iso-
thiouronium bromide-treated sheep red cells as described earlier [9) . 
They contained less than 1% latex ingesting cells, less than 5% lg-
positive cells, and more than 75% E rosette-forming cells. 
Preparation of Adherent Cells/ Monocytes 
Adherent cells were prepared from peripheral blood monocytes by 
means of adherence as described earlier [6). The viability was usu"ally 
more than 95% and determined by trypan blue exclusion. More than 
80% ingested latex particles, and about 90% were HLA-DR-positive 
when stained with rabbit anti-DR antiserum. They are called mono· 
cytes ( Mo) hereafter. 
Preparation of Ec and Enriched Lc 
Epidermis was separated from dermis at the basement membrane in 
vivo by means of a suction blister device [10). The sheets of epidermis 
obtained were then dissociated by means of trypsin, washed, and 
suspended in medium RPMI 1640 with L-glutamine (Gibco-Bio-Cult, 
Glasgow, Scotland) supplemented with penicillin, streptomycin, and 
20% normal human serum. Viability was usually more than 90% and 
the cell suspensions contained 2- 6% OR-positive cells. No peroxidase-
positive monocytes/macrophages were detected in the epidermal cell 
suspensions. Lc were then separated from the majority of Ec using a 
rosette-forming technique as previously described [11] . In short, Lc 
were sensitized with the monoclonal antibody OKT6. This suspension 
was then mixed with ox red blood cells (ORBC) coated with rabbit 
antimouse IgG antiserum. Within 1 h at 37"C rosettes were formed 
and separated from the Ec by Percoll flotation . The OKT6+ Lc were 
recovered from the pellet after hemolysis of the ORBC. The mean 
percentage of rosette-forming OKT6+ Lc in the pellet was 69% ± 16. 
Cell Culture Technique 
Lymphocytes (5 X 10') were cocultured with various numbers of 
autologous APC such as Ec, enriched Lc, or Mo with or without CA 
and HSV in the wells of round-bottomed microtiter plates (Model 15-
MRC 96, Linbro Scientific, Inc., Hamden, Connecticut) in a human 
5% C02 atmosphere at 37"C for 7 days. Each well contained 170 111 
Medium RPMI -1640 supplemented with antibiotics and 20% normal 
human serum. [3H]Thymidine was added 18 h before harvesting, which 
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was performed with a semiautomatic multiple cell cu lture harvester 
(Skatron, Lierbyen, Norway). Incorporation was measured by means 
of a liquid scin ti llation counter and expressed as the mean of t riplicate 
cultu r es ± SE. 
RESULTS 
T-Cell Response to CA Requires Moor Ec as APC 
The T-lymphocyte response to CA is dependent upon APC, 
as depicted in Table I. While sensitized T cell s alone did not 
respond, both Mo and Ec were capable of inducing an antigen-
specific response of autologous T lymphocytes in vitro. Ec also 
appeared more efficient than similar numbers of Mo. When the 
Ec were first pretreated with ant i-DR antiserum, the antigen-
presenting capacity of Ec was lost (Table II, upper part) . 
We t hen compared in more detail the ability of various 
numbers of Ec, containing 3- 5% DR-posit ive Lc, and Mo, 
containing more than 90% DR-positive cells, to act as APC for 
5 x 104 cells. Fig 1 shows a typical experiment. TheCA response 
reached a peak at 5- 10 x 10'1 Mo added, declining with further 
increase in number of Mo. In con trast, t he response in cultures 
using Ec as APC increased in proportion with the number of 
Ec added, up to the highest tested number of Ec; 1.5 X 105. At 
t his number of Ec, the response was 7- 8 times higher than the 
maximum response seen with Mo as APC. 
Enriched Lc as APC 
Lc was enriched from Ec and used as APC for autologous T 
cells fro m sensitized donors. The kinet ics of the T -lymphocyte 
respon se is illustrated in Fig 2 using 500 and 1000 Lc as APC 
for 5 x 104 T cells. The peak response was seen on day 7. In 
some experiments various dilutions of ant igen were used, rang-
ing from 10- 2 to 10-5• The response increased with increasing 
concen tration of ant igen, with a peak response at t he highest 
concentration used (dilut ion 10- 2). We then compared enriched 
Lc with Mo. Suspensions of Lc (containing 69% (range, 50-
92 % ) OKT6+ cells) and suspensions of Mo (containing more 
t han 90% DR-positive cells) were used. The ability of various 
numbers of Lc and Mo to induce T -cell proliferation to CA and 
HSV was tested. The results of two typical experiments are 
shown in Fig 3a and b. It appears that as few as 100-500 Lc 
TABLE I. Epidermal cell (Ec)- and monocyte (Mo)-dependen.t 
T -ly m.phocyte response to Candida antigen" 
Exp no. T cells• T+Mo' 
1 334 ± 49" 8866 ± 1269 
2 283 ±58 3498 ± 829 
3 223 ± 47 9349 ± 924 
4 325 ± 72 nt 
5 195 ± 70 nt 
6 192 ± 43 nt 
a 10-2 C. albican.s dilutions added to t he well s. 
• 5 X 10' T cells. 
'5 x 10" monocytes. 
d 5 X 10' epiderma l cells. 
• Mean cpm ± SE. 
T +Ecd 
56878 ± 7140 
25733 ± 4510 
44374 ± 3487 
10743 ± 306 
28300 ± 861 
26134 ± 4255 
were able to induce significant antigen-specific responses of 5 
x 104 sensitized T cells. At a concentration of 100- 1000 Lc per 
5 X 10' T cells, no response was seen without antigen (CA or 
HSV) added, i.e., no autologous mixed leukocyte reaction 
(MLR) was seen [11]. Furthermore, it appears t hat Lc, on a 
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FIG 1. Influence of the number of epidermal cells (Ec) and mono· 
cytes (Mo) as antige~·p resenting cells on the response of 5 X 10' T 
cells to Candrda antigen. Values are mean cpm ± SE of trip licate 
cultures. 
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FIG 2. Kinetics of ~h e response of 5 x 10' T cells to Candida antigen 
(CAND) a~d herpes s tmplex vtrus (HSV) , using enriched Langerhans 
cells as antJgen-presentmg cells. Values are mean cpm ± SE of tripli -
cates. 
TABLE U. Effect of treatment of epidermal cells (Ec-upper part of table) and enriched Langerhans cells (Lc- lower part) with anti-DR antiserum 
or normal rabbit serum on the autologous T-lymphocyte response to CA and HSV 
No. of No. of An tigen 
Ec X 10' Lc X JO' 
2 CA 
5 CA 
10 CA 
1 CA 
1 HSV 
"Epidermal cells or enriched Lc treated with normal rabbit serum. 
• Epidermal cells or enriched Lc t reated wit h a nti-DR serum. 
' cpm ± SE of t riplicates. 
Unt reated NRS. Anti ·DR 
Ec treated Ec or Lc" t reated Ec or Lc• 
2796 ± 1805 ' 2291 ± 874 191 ± 61 
5509 ± 1849 6491 ± 3543 331 ± 26 
6852 ± 1294 4111±1712 316 ± 42 
10384 ± 4864 11120 ± 4806 1118 ± 822 
4964 ± 1670 4088 ± 1009 1132 ± 703 
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FIG :3. In!luence of the number of enriched Langerhans cells (Lc) 
and monocytes (M o) as a ntigen-prese nting cells on the T -cell response 
to Candida a nti gen (a) and herpes simplex virus (b). Values are cpm ± 
SE of triplicates. 
per cell basis, is much more potent as APC than Mo. Due to 
lack of a sufficient number of Lc, it was not poss ible to test 
higher numbers of Lc than 2500. 
The combined results of 11 experiments using HSV and CA 
are shown in F ig 4. When the Lc were first pretreated with 
anti -DR antiserum and complement, their antigen -presenting 
function was lost (Table Il , lower part) . 
DISCUSSION 
We report here that Ec as well as Lc enriched from Ec 
suspensions are able to replace Mo in their abi li ty to present 
CA and HSV in an immunogenic way toT lymphocytes. Fur-
thermore, Lc on a per cell basis induce stronger a11tigen-specific 
responses than do Mo. Evidence was also obtained that the 
cells responsible for these functions carry the HLA-DR mole-
cules. 
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FIG 4. Inf1uence of various numbers of enriched Langerhans cells 
(solid lines) a nd monocytes (brohen lines ) as APC on the T-cell response 
to Candida antigen (CA) and herpes simplex virus (HSV) . The data 
are pooled from 11 experiments, and expressed as mean cpm ± SE. 
Epidermal ce ll s are able to present so luble antigens in an 
immunogenic way to T lymphocytes. This was first shown in 
the gu inea pig [12) and later in humans using different antigens 
such as purified protein derivative of tubercu lin (PPD) , herpes 
simplex virus antigen (HSV -Ag), live herpes virus (HSV), 
varicella antigen, and the contact allergen nickel 
sulfate [5,6,9,13). Here we show that this is a lso true for CA. 
Furthermore, stronger T-cell responses were obta ined when Ec 
rather than similar numbers of Mo were used as APC. In our 
experiments over 90% of the Mo were DR-positive while only 
3- 5% of the Ec were shown to react with t he anti-DR anti-
serum. Thus from Fig 3a one can estimate that 7- 8 times 
stronger responses were seen using 5- 10 X 10" Lc (contained 
in 1.5 X 105 Ec) tha n using a similar number of Mo (5- 10 X 
10'1 Mo) as APC. Similar results have been obtained with other 
antigens [9]. 
Characterization and functional studies on human Lc have 
been hampered by the low proportion of Lc in epidermis and 
stratified squamous epithe lium [14). Different methods have 
been used to enrich Lc, but usua lly less than 40% Lc was 
obtained [15). Flow cytometry sorting with Ec from guinea-
pigs [15) has resulted in approximately the same percentage of 
enrichment as we obtained with our rosette-forming technique 
(70- 90%). Flow cytometry is, however, a very time-consuming 
and difficult procedure, which would require more epidermis 
t han would be acceptab le to take from humans in vivo. Our 
method used for separation of human Lc is rapid, it is repro-
ducible, and sterile suspensions can be obtained. The method 
provides a positive selection of cells with the T6 antigen. OKT6 
was chosen instead of OKial, since OKT6 does not inhibit Ec-
dependent activation ofT ce lls [11], which may be a problem 
using antibodies against class II HLA molecules [5,9]. Further-
more , we have previously shown that OKT6 has no mitogenic 
effect on T lymphocytes alone [11], in contrast to what has 
been reported with certain other monoclonal mouse anti human 
antibodies [16). 
Using t his enrichment procedure [11], Lc suspensions could 
be prepared containing 50-92% OKT6+ cells. On a per cell 
basis we could directly demonstrate that the Lc are much more 
potent APC t han are Mo in inducing T-cell proliferation to 
HSV and CA (Figs 3, 4). 
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Recent studies have shown t hat human blood-derived Mo 
contribute li ttle if at all to accessory cell function when they 
are deprived of t heir contents of dendritic cells (De) (17] . De 
constitute less than 1% of blood mononuclear cells (7]. In 
contrast, highly enriched and Mo-depleted De are potent as 
stimulators of autologous and a llogeneic MLR and as APC in 
the response to soluble antigens such as tetanus toxoid. Most, 
if not all, Mo and De exhibit similar numbers of class II 
molecules per cell - approximately 150,000 [18]. Thus, since De 
are active accessory cells, while class II positive Mo apparently 
are not, class II products as such are necessary but not sufficient 
alone for stimulation of aT -cell response in humans. In mixing 
experiments, when graded numbers of purified Mo have been 
added to antigen-presenting De, we have observed a strong 
inhibition of APC function with ratios of Mo:Dc of 15:1 and 
5: 1 (to be published). The data reported here comparing Mo 
and Ec or Lc (see Table I and Fig 1) are compatible with these 
findings . It will be important to compare peripheral blood-
derived De with enriched Lc with respect to APC function , 
using different antigens. Such studies are under way. 
Keratinocytes have been reported to produce ETAF, which 
is similar to interleukin 1 (IL-l) produced by macrophages 
[19]. One might, therefore, speculate that Lc cannot function 
outside the epithelial microenvironment. Even t hough we were 
not able to obtain 100% pure suspensions of Lc, our results 
suggest that the Lc can induce antigen-specific T-cell response 
alone without the contribut ion of keratinocytes. It will be 
important to investigate whether Lc produce IL-l. However, 
our data indicate that Lc function as APC also outside the 
microenvironment in which they are situated, e.g., epidermis 
or squamous epithelium. 
The secretarial ass istance of Kristi Goyer was greatly appreciated. 
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